State Street’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
495,862
+1,474
| +0.3% | +$9.91K | ﹤0.01% | 3110 |
|
|
2025
Q1 | $4.47M | Sell |
494,388
-10,591
| -2% | -$95.7K | ﹤0.01% | 2927 |
|
|
2024
Q4 | $8.73M | Buy |
504,979
+35,378
| +8% | +$612K | ﹤0.01% | 2707 |
|
|
2024
Q3 | $7.5M | Buy |
469,601
+24,385
| +5% | +$390K | ﹤0.01% | 2766 |
|
|
2024
Q2 | $6.34M | Buy |
445,216
+9,826
| +2% | +$140K | ﹤0.01% | 2815 |
|
|
2024
Q1 | $6.17M | Buy |
435,390
+7,558
| +2% | +$107K | ﹤0.01% | 2837 |
|
|
2023
Q4 | $6.46M | Buy |
427,832
+24,579
| +6% | +$371K | ﹤0.01% | 2823 |
|
|
2023
Q3 | $6.37M | Buy |
403,253
+12,062
| +3% | +$191K | ﹤0.01% | 2812 |
|
|
2023
Q2 | $5.92M | Buy |
391,191
+326,614
| +506% | +$4.94M | ﹤0.01% | 2914 |
|
|
2023
Q1 | $936K | Buy |
64,577
+54
| +0.1% | +$783 | ﹤0.01% | 3549 |
|
|
2022
Q4 | $872K | Buy |
64,523
+31,229
| +94% | +$422K | ﹤0.01% | 3589 |
|
|
2022
Q3 | $525K | Buy |
33,294
+3,100
| +10% | +$48.9K | ﹤0.01% | 3762 |
|
|
2022
Q2 | $368K | Sell |
30,194
-121,000
| -80% | -$1.47M | ﹤0.01% | 3959 |
|
|
2022
Q1 | $1.42M | Buy |
151,194
+70,075
| +86% | +$658K | ﹤0.01% | 3692 |
|
|
2021
Q4 | $1.39M | Buy |
+81,119
| New | +$1.39M | ﹤0.01% | 3741 |
|